B&D White Capital Company’s Pfizer PFE Stock Holding History

B&D White Capital Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-496,760	Closed	-$16.5M	–	79
2023 Q3	$16.5M	Sell	496,760 -367,335	-43%	-$13M	6.15%	6
2023 Q2	$31.7M	Buy	864,095 +505,454	+141%	+$19.7M	10.95%	3
2023 Q1	$14.6M	Buy	+358,641	New	+$15.5M	4.96%	5
2022 Q4	–	Sell	-1,254,405	Closed	-$54.9M	–	110
2022 Q3	$54.9M	Buy	1,254,405 +1,236,800	+7,025%	+$60.1M	20.54%	1
2022 Q2	$923K	Sell	17,605 -200	-1%	-$10.2K	0.39%	30
2022 Q1	$921K	Sell	17,805 -11,900	-40%	-$617K	0.29%	35
2021 Q4	$1.75M	Sell	29,705 -42	-0.1%	-$2.08K	0.58%	24
2021 Q3	$1.28M	Sell	29,747 -73	-0.2%	-$3.23K	0.49%	41
2021 Q2	$1.17M	Sell	29,820 -543,419	-95%	-$21.1M	0.52%	25
2021 Q1	$19.2M	Sell	573,239 -102,396	-15%	-$3.64M	10.2%	2
2020 Q4	$25M	Buy	+675,635	New	+$24.8M	14.23%	2

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

B&D White Capital Company's PFE Position: Q4 2023 in Review

B&D White Capital Company sold out of Pfizer (PFE) in Q4 2023, closing a stake of 496,760 shares — an estimated $16.5M sold.

B&D White Capital Company first reported a position in PFE in Q4 2020 and held it in 11 quarters. The position peaked at $54.9M in Q3 2022. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

B&D White Capital Company reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
B&D White Capital Company sold 496,760 Pfizer shares in Q4 2023, an estimated $16.5M.
B&D White Capital Company first reported a position in Pfizer in Q4 2020 and held it in 11 quarters.
B&D White Capital Company's Pfizer position peaked at $54.9M in Q3 2022.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on B&D White Capital Company's 13F filing for Q4 2023, filed 30 Jan 2024.